Skip to main content

Melphalan Flufenamide Hydrochloride

(MEL-fuh-lan floo-FEH-nuh-mide HY-droh-KLOR-ide)

This page contains brief information about melphalan flufenamide hydrochloride and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Pepaxto
FDA Approved
Yes

FDA label information for this drug is available at DailyMed.

Use in Cancer

Melphalan flufenamide hydrochloride is approved to be used with dexamethasone to treat:

This use is approved under FDA’s Accelerated Approval Program. As a condition of approval, confirmatory trial(s) must show that melphalan flufenamide hydrochloride provides a clinical benefit in these patients.

Melphalan is also available in other forms. For more information, see the Drug Information Summaries for Melphalan and Melphalan Hydrochloride.

Melphalan flufenamide hydrochloride is also being studied in the treatment of other types of cancer.

More About Melphalan Flufenamide Hydrochloride

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

Targeted Cancer Therapies

Clinical Trials Accepting Patients

Find Clinical Trials for Melphalan Flufenamide Hydrochloride - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted:
  • Updated: